U.K. mulls R&D tax credits for midsize biotechs

12/3/2004 | Reuters

The U.K.'s chancellor of the exchequer says he intends to review a tax credit given to medium-sized biotech and drug companies for research and development with an eye to increasing them as a way to encourage the industry. Gordon Brown also said he would end tax barriers that block spin-off companies created by universities. The drug industry applauded the promised move.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC